Trial Details
RECRUITINGBasic Information
| Clinical ID | c230 |
|---|---|
| Identifier | NCT06925594 |
| Trial Title | Phase 3 Study of Human TH-SC01 Cell Injection for Treating Perianal Fistulas in Patients With Crohn's Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease |
| Interventions | OTHER: Human TH-SC01 cell injection|OTHER: Saline solution |
Participant Information
| Sponsor | Jiangsu Topcel-KH Pharmaceutical Co., Ltd. |
|---|---|
| City | Nanjing |
| Country/Region | China |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-03-20 |
|---|---|
| Primary Completion Date | 2026-12-28 |
| Completion Date | 2028-06-28 |